Page 144 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
        P. 144
     PC-26
               Combining computational profiling and isolation of zoanthamine alkaloids
               from Zoanthus sp.: A promising strategy for targeting DKK1 and GSK-3β in
               osteoporosis therapy
                                                                         1
                                                                                         1
                                  #,1
               Ngoc-Thac Pham,  Bo-Rong Peng,       1,2,3  Huong-Giang Le,  Lo-Yun Chen,  Mei-Hsien
                    4
               Lee,  Kuei-Hung Lai*   ,1,2,5
               1  PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy,
                 Taipei Medical University, Taipei 110301, Taiwan
               2  Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University,
                 Taipei 110301, Taiwan
               3  Graduate Institute of Healthy Industry Technology, Center for Drug Research and
                 Development, College of Human Ecology, Chang Gung University of Science and
                 Technology, Taoyuan 333324, Taiwan
               4  Center for Reproductive Medicine and Sciences, Taipei Medical University Hospital, Taipei
                 110301, Taiwan
               5  Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei
                 110301, Taiwan
               * E-mail: kueihunglai@tmu.edu.tw
               Abstract
                  Marine  invertebrates  from  the  genus  Zoanthus  are  notable  for  producing  a  variety  of
               biologically active secondary metabolites with  significant  pharmaceutical  potential. Among
               these,  zoanthamines  -  a  class  of  alkaloids  -  are  particularly  promising  for  treating  health
               conditions like osteoporosis, a disease marked by decreased bone density and higher fracture
               risk. This condition is closely linked to disruptions in the Wnt signaling pathway, crucial for
               bone health and cellular processes. Targeting pathway regulators like DKK1 and GSK-3β offers
               a strategic approach for developing osteoporosis treatments. This study employed an integrative
               computational approach to examine zoanthamine alkaloids as potential inhibitors of DKK1 and
               GSK-3β.  69  derivatives  were  assessed  through  molecular  docking  to  predict  their  binding
               affinities. Molecular dynamics simulations provided insights into the stability and dynamics of
               protein-ligand  interactions,  focusing  on  parameters  such  as  RMSD,  RMSF,  and  radius  of
               gyration. The  MM-PBSA  method,  combined  with  interaction  entropy,  identified  promising
               candidates. Zoanthus kuroshio extracts exhibited significant in vitro anti-osteoporotic activity,
               leading to the isolation and characterization of five new zoanthamine alkaloids. Notably, 3-
               hydroxynorzoanthamine showed enhanced alkaline phosphatase activity and mineralization in
               osteoblastic cells, demonstrating strong therapeutic potential. The study highlights the potential
               of zoanthamine alkaloids in osteoporosis therapy, underscoring the value of marine natural
               products as sources for drug development. Future research should focus on pharmacokinetic,
               pharmacodynamic, and clinical evaluations to translate these findings into effective treatments,
               fully exploiting the therapeutic potential of marine-derived compounds.
               Keywords: Zoanthus sp; Molecular dynamics; Osteoporosis; Isolation; Zoanthamine alkaloids





